Email Us Here

TaiwanJ Pharmaceuticals Gains FDA Approval for Entering Phase 2 Clinical Study on Autoimmune Hepatitis, an Orphan Disease

TaiwanJ Pharmaceuticals announced that the US Food and Drug Administration (FDA) had approved its IND application for the Phase 2 clinical trial of JKB-122